EUVIMEDEUVIMED entdecken
Crossref

Association between group B major ABO ‐incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α‐gal syndrome. A Biomedical Excellence for Safer Transfusion Collaborative study

Lucile Malard, Cléo Beuscart, Luc de Chaisemartin, Virginie de la Taille, Fanny Delettre, Catherine Humbrecht, Nancy Dunbar, Sophie Lecam iD, Syria Laperche iD, Pierre Tiberghien iD, Biomedical Excellence for Safer Transfusion (BEST) Collaborative

Vox Sanguinis · 2026

DOI: 10.1111/vox.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Lucile Malard und 10 weiteren Autor:innen. Beteiligte Einrichtung: Établissement Français du Sang, La Plaine Saint-Denis, France. Hauptthemen laut MEDLINE: ABO Blood-Group System, Platelet Transfusion, Blood Group Incompatibility, Transfusion Reaction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Severe transfusion reactions to group B–incompatible platelets and plasma possibly related to the α‐gal syndrome ( AGS ) have been recently described. AGS is a potentially severe Immunoglobulin E mediated allergy to mammalian meat and meat‐derived products associated with tick bites. The involved allergen, galactose‐α‐1,3‐galactose (α‐gal), is antigenically similar to the blood group B antigen. To further assess a potential association between AGS and allergic transfusion reactions (ATRs), we comparatively assessed the frequency of ATRs after plasma or platelet concentrate (PC) transfusion in relation to the degree of ABO compatibility between the recipient and the involved blood component in France. Materials and Methods In France, all transfusions are centrally recorded, and ATR reporting is mandatory. Frequencies of severe ATRs involving PC or plasma in relation to ABO group distributions were analysed between 1 January 2022 and 31 December 2024.

Results

Among 981,955 PC and 580,230 plasma evaluable transfusions, severe ATRs were significantly higher in group O recipients transfused with group B or AB platelets (relative risk [RR]: 5.06, 95% confidence interval [CI]: 3.27–7.83, p < 0.001) and plasma (RR: 2.15, 95% CI: 1.37–3.36, p < 0.001) while not in group A recipients of group B or AB platelets (RR: 0.95, 95% CI: 0.30–2.96) or plasma (RR: 0.92, 95% CI: 0.45–1.88), when compared to ATR rates in all other recipients of PC or plasma, respectively.

Conclusion

In this national retrospective haemovigilance analysis, group B or AB PC or plasma transfused to group O recipients is associated with an increased risk of severe ATRs . Further studies will establish whether AGS is involved in this increased risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ABO Blood-Group SystemPlatelet TransfusionBlood Group IncompatibilityTransfusion ReactionPlasmaHypersensitivityBlood Component TransfusionHumansMaleFemaleFranceMiddle AgedAdultBlood Safety

Stichwörter der Autor:innen

B major ABO‐incompatible transfusionallergic transfusion reactionplasma transfusionplatelet transfusionα‐gal syndrome

Substanzen

ABO Blood-Group System

Autor:innen und Institutionen

  • Établissement Français du Sang, La Plaine Saint-Denis, France.
  • Service d'Immunologie Biologique, CHU Bichat, AP-HP, Paris, France.
  • UMR 1149, Université Paris Cité, INSERM, Centre de Recherche sur l'Inflammation, Equipe InnaLung, Paris, France.
  • Établissement Français du Sang, Besançon, France.
  • UMR RIGHT 1098, Université Marie et Louis Pasteur, INSERM, Etablissement Français du Sang, Besançon, France.
  • Établissement Français du Sang, Nancy, France.

ORCID-Profile: Sophie Lecam, Syria Laperche, Pierre Tiberghien

Zitieren

APA

Malard, L., Beuscart, C., de Chaisemartin, L., de la Taille, V., Delettre, F., Humbrecht, C., Dunbar, N., Lecam, S., Laperche, S., Tiberghien, P., & Biomedical Excellence for Safer Transfusion (BEST) Collaborative (2026). Association between group B major ABO ‐incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α‐gal syndrome. A Biomedical Excellence for Safer Transfusion Collaborative study. Vox Sanguinis. https://doi.org/10.1111/vox.70136

Vancouver

Malard L, Beuscart C, de Chaisemartin L, de la Taille V, Delettre F, Humbrecht C, et al. Association between group B major ABO ‐incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α‐gal syndrome. A Biomedical Excellence for Safer Transfusion Collaborative study. Vox Sanguinis. 2026. doi:10.1111/vox.70136

BibTeX
@article{Malard2026,
  author = {Malard, Lucile and Beuscart, Cléo and de Chaisemartin, Luc and de la Taille, Virginie and Delettre, Fanny and Humbrecht, Catherine and Dunbar, Nancy and Lecam, Sophie and Laperche, Syria and Tiberghien, Pierre and Biomedical Excellence for Safer Transfusion (BEST) Collaborative, Biomedical Excellence for Safer Transfusion (BEST) Collaborative},
  title = {Association between group B major ABO ‐incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α‐gal syndrome. A Biomedical Excellence for Safer Transfusion Collaborative study},
  journal = {Vox Sanguinis},
  year = {2026},
  doi = {10.1111/vox.70136}
}
Kostenlos starten →